DEADLINE NOW CLOSED: Lymphoma Canada is no longer accepting applications for 2021 research funding

CANADIAN RESEARCHERS AND HEALTHCARE PROFESSIONALS WERE INVITED TO APPLY TO LYMPHOMA CANADA’S 2021 RESEARCH GRANTS PROGRAM BY APRIL 30th 2021.

THANK YOU TO OUR MANY APPLICANTS. REVIEW IS UNDERWAY. YOU WILL BE NOTIFIED OF YOUR APPLICATION STATUS.

APPLICATION DEADLINE: NOW CLOSED

The Lymphoma Canada Research Awards are intended to support small, well-defined research studies that have the potential to effect improvements in healthcare, health systems, and/or health outcomes as they pertain to malignant lymphoproliferative diseases.

Proposed research studies may address any of the following broad areas of research, including but
not limited to:
• patient-reported outcomes;
• comparative clinical effectiveness;
• pharmaco-economics; or
• health care utilization.

Each grant consists of a one-time payment to a maximum of $25,000, dependent on the nature and budget of the research study. Research studies are to be completed within the agreed-upon term of the study but will not exceed two years from the grant start date.

Canadian researchers and healthcare professionals at any stage of their career, including allied health professionals, were invited to apply.